1. Home
  2. APRE vs STRM Comparison

APRE vs STRM Comparison

Compare APRE & STRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • STRM
  • Stock Information
  • Founded
  • APRE 2006
  • STRM 1989
  • Country
  • APRE United States
  • STRM United States
  • Employees
  • APRE N/A
  • STRM N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • STRM EDP Services
  • Sector
  • APRE Health Care
  • STRM Technology
  • Exchange
  • APRE Nasdaq
  • STRM Nasdaq
  • Market Cap
  • APRE 13.5M
  • STRM 15.4M
  • IPO Year
  • APRE 2019
  • STRM 1996
  • Fundamental
  • Price
  • APRE $1.80
  • STRM $2.59
  • Analyst Decision
  • APRE Strong Buy
  • STRM
  • Analyst Count
  • APRE 2
  • STRM 0
  • Target Price
  • APRE $15.50
  • STRM N/A
  • AVG Volume (30 Days)
  • APRE 21.0K
  • STRM 5.8K
  • Earning Date
  • APRE 05-13-2025
  • STRM 04-28-2025
  • Dividend Yield
  • APRE N/A
  • STRM N/A
  • EPS Growth
  • APRE N/A
  • STRM N/A
  • EPS
  • APRE N/A
  • STRM N/A
  • Revenue
  • APRE $1,502,581.00
  • STRM $18,587,000.00
  • Revenue This Year
  • APRE N/A
  • STRM N/A
  • Revenue Next Year
  • APRE N/A
  • STRM $4.04
  • P/E Ratio
  • APRE N/A
  • STRM N/A
  • Revenue Growth
  • APRE 157.63
  • STRM N/A
  • 52 Week Low
  • APRE $1.85
  • STRM $1.85
  • 52 Week High
  • APRE $6.70
  • STRM $9.75
  • Technical
  • Relative Strength Index (RSI)
  • APRE 26.70
  • STRM 28.44
  • Support Level
  • APRE $1.85
  • STRM $2.18
  • Resistance Level
  • APRE $2.30
  • STRM $3.22
  • Average True Range (ATR)
  • APRE 0.16
  • STRM 0.20
  • MACD
  • APRE -0.01
  • STRM -0.03
  • Stochastic Oscillator
  • APRE 2.50
  • STRM 45.08

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About STRM Streamline Health Solutions Inc.

Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.

Share on Social Networks: